Calprotectin testing sales will expand through 2036, with calprotectin ELISA test kits holding a 58% share of the product segment in 2026. The market is expected to reach USD 54.3 billion in 2026 and USD 98.1 billion by 2036, creating an absolute opportunity of USD 43.8 billion between 2026 and 2036.